News | July 22, 2014

Researchers Show Edge Radiosurgery System Can Target Cancer with Sub-millimeter Accuracy

Seven presentations at the 2014 American Association of Physicists in Medicine (AAPM) meeting focus on early adopters' work with Varian's Edge radiosurgery

July 22, 2014 — Medical researchers have confirmed the Edge radiosurgery system from Varian Medical Systems can deliver dose to a targeted tumor with sub-millimeter isocenter accuracy.  The researchers, from the Champalimaud Centre for the Unknown in Lisbon, Portugal, and other teams from the Henry Ford Health System in Detroit, Michigan, made seven scientific presentations about the Edge system during the 2014 American Association of Physicists in Medicine (AAPM) meeting from July 20-24. 

The Champalimaud team worked with scientists from Varian to conduct "end-to-end" testing of the Edge system, to demonstrate its diverse subsystems can work together to yield sub-millimeter accuracy when delivering dose.

Investigators from the Henry Ford Health System did early work with the Edge radiosurgery system covering a wide spectrum of clinical issues, from the accuracy of patient setup for image-guided intracranial (brain) radiosurgery to methods for accurately commissioning a new Edge system. One of the Henry Ford teams presented preliminary data on the accuracy of dose calculations for treating small, elongated tumors with radiosurgery. 

The Edge radiosurgery suite combines Varian's world-class technologies in an end-to-end solution for planning and delivering radiosurgery treatments. It integrates Varian's most advanced medical linear accelerator — a machine that produces the high energy X-ray beams used to treat disease — with tools for real-time imaging, tumor tracking, motion management and patient positioning. The Edge enables fast, accurate delivery of stereotactic radiosurgery for treating lesions, tumors and conditions anywhere in the body where radiotherapy is indicated, including tumors of the lung, prostate, spine and brain.

For more information: www.varian.com

Related Content

Immune Inflammatory Levels Linked to Disease-Free Survival in Prostate Cancer
News | Prostate Cancer | November 19, 2018
Data from a validation study of a high-risk prostate cancer trial suggests that higher levels of pretreatment...
Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation